Navigation Links
BioAmber Issues Statement Required by Section 610(b) of the NYSE MKT Company Guide
Date:3/16/2017

MONTREAL, March 16, 2017 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA), today announced that its audited consolidated financial statements for the fiscal year ended December 31, 2016, which were included in the Company's Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 16, 2017, contained a going concern qualification from its registered independent public accounting firm. This announcement is made in accordance with NYSE MKT Company Guide Section 610(b), which requires separate disclosure of receipt of an audit opinion containing a going concern qualification. This announcement does not represent any change or amendment to the Company's audited financial statements or to its Annual Report on Form 10-K for the fiscal year ended December 31, 2016.

About BioAmber
BioAmber (NYSE: BIOA) is a renewable materials company. Its innovative technology platform combines biotechnology and catalysis to convert renewable feedstock into building block materials that are used in a wide variety of everyday products including plastics, paints, textiles, food additives and personal care products. For more information visit www.bio-amber.com


'/>"/>
SOURCE BioAmber Inc.
Copyright©2017 PR Newswire.
All rights reserved


Related biology technology :

1. BioAmber Announces Webcast of Fiscal Fourth Quarter And Full 2016 Financial Results
2. BioAmber CEO steps down, current COO Fabrice Orecchioni named President
3. BioAmber announces reimbursement of corporate debt and closing of public offering
4. BioAmber Inc. increases previously announced public offering to US$17.5 million
5. BioAmber Inc. announces US $10 million underwritten public offering
6. BioAmber Inc. announces $7 million underwritten offering of common stock and concurrent $8.9 million registered direct offering of warrants
7. BioAmber and CJ CheilJedang Plan JV for Succinic Acid Production in Asia
8. DuPont Tate & Lyle Bio Products and BioAmber Launch New Sampling Program at UTECH NA
9. BioAmber Announces Year End Operational and Financial Results for 2015
10. BioAmber Announces Webcast of Fiscal Fourth Quarter and Full 2015 Financial Results
11. BioAmber Announces Changes to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... AxioMed president, Jake Lubinski, describes ... characteristics when deformed, which is identical to how the human discs work to ... and return to its natural state along a hysteresis curve, exactly like a ...
(Date:3/23/2017)... -- GlobeImmune, Inc. today announced it has entered into a ... of its common stock to NantCell, Inc., a member ... sale of its common stock, NantCell has agreed to ... 200,000 shares, an estimated $2.0 million in value, of ... to enter into this strategic agreement with NantCell," said ...
(Date:3/23/2017)... York , March 23, 2017 According ... plasma products and derivatives market is fragmented due to the presence of ... such as Proliant, Thermo Fisher , and Sigma-Aldrich, compete with ... these three companies, collectively, held more than 76% of this market ... As ...
(Date:3/22/2017)... ... March 22, 2017 , ... Researchers face a ... lab samples to full-size tissues, bones, even whole organs to implant in people ... delivers blood deep into the developing tissue. , Current bioengineering techniques, including ...
Breaking Biology Technology:
(Date:2/10/2017)... Feb 10, 2017 Research and ... "Personalized Medicine - Scientific and Commercial Aspects" to ... ... Diagnosis is integrated with therapy for selection of treatment as ... detection and prevention of disease in modern medicine. Biochip/microarray technologies ...
(Date:2/8/2017)... YORK , Feb. 8, 2017 About ... individual,s voice to match it against a stored ... such as pitch, cadence, and tone are compared ... require minimal hardware installation, as most PCs already ... for different transactions. Voice recognition biometrics are most ...
(Date:2/8/2017)... Report Highlights ... The global synthetic-biology market reached nearly $3.9 billion in ... a compound annual growth rate (CAGR) of 24.0% through 2021. ... for synthetic biology. - Analyses of global market trends, with ... annual growth rates (CAGRs) through 2021. - Coverage of core ...
Breaking Biology News(10 mins):